Membership deepens ENPICOM's commitment to advance AI and autonomous agent infrastructure for life sciences R&D
"The Pistoia Alliance's focus on the infrastructure challenges that stand between AI's promise and its impact on pharma R&D aligns closely with our own," said Nicola Bonzanni, Founder and CEO of ENPICOM. "The standardization, interoperability, and automation needed to operationalize AI and autonomous agents are the same challenges we work on every day. That shared mission is exactly why we joined."
The Pistoia Alliance brings together more than 200 member organizations, including top pharmaceutical companies, CROs, technology providers, and academic institutions, to tackle shared R&D challenges through pre-competitive collaboration. As a member, ENPICOM will actively engage in the Alliance's projects, communities, and events alongside peers across the biopharmaceutical value chain.
About the Pistoia Alliance
The Pistoia Alliance is a global, not-for-profit members’ organization made up of life science companies, technology and service providers, publishers, and academic groups working to lower barriers to innovation in life science and healthcare R&D. It was conceived in 2007 and incorporated in 2009 by representatives of AstraZeneca, GSK, Novartis, and Pfizer who met at a conference in Pistoia, Italy. Its projects transform R&D through pre-competitive collaboration. It overcomes common R&D obstacles by identifying the root causes, developing standards and best practices, sharing pre-competitive data and knowledge, and implementing technology pilots. There are currently over 200 member companies; members collaborate on projects that generate significant value for the worldwide life sciences R&D community, using the Pistoia Alliance’s proven framework for open innovation.
About ENPICOM
ENPICOM is a bioinformatics and AI company accelerating biologics discovery and development. Its digital platform unifies data, automates analysis, and integrates AI into scientists' daily workflows, helping life sciences organizations develop better medicines, faster. For more information, visit enpicom.com.